CHICAGO -- A single infusion of the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel (cilta-cel; ...

WASHINGTON (AP) -- The Trump administration announced on Tuesday that it would revoke guidance to the nation's hospitals that ...

Among patients who received four-drug consolidation therapy, 84% had measurable residual disease (MRD)-negative status before ...

LOS ANGELES -- For Xavier Becerra, who was the HHS secretary during the Biden administration and now a candidate for ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

Unpredictable and politically driven regulatory approaches cultivate an environment of enormous uncertainty for vaccine ...

As we brace for hotter summers and more erratic weather patterns nationwide, we must see this pollen surge not as an isolated ...

A single-center study supported recommendations to lower the colorectal cancer screening age from 50 to 45. A single-center ...

Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

Nearly 5 million Americans with diabetes would qualify to use a GLP-1 receptor agonist for primary stroke prevention but few ...

The FDA approved treprostinil (Yutrepia) inhalation powder for pulmonary arterial hypertension and pulmonary hypertension ...